Refresh Laser Clinic

Broker's Calls

Accrelist's fintech businesses risky but can be rewarding: NRA

SINGAPORE (June 1): NRA Capital is rating Accrelist at “overweight” with a fair value of 1.2 cents but has classified the stock pick as “high risk” as the new businesses are still in the infancy stage.
×